December 19, 2014 16:12 (IST)
City-based drug maker Dr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.
December 17, 2014 19:31 (IST)
Swiss drug maker Novartis AG said on Wednesday it had sued Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price.
December 16, 2014 19:27 (IST)
Home grown FMCG firm Emami has enetered into a partnership with German homoeopathic firm Hevert-Arzneimittel for manufacturing and marketing of select Hevert formulations in India.
December 16, 2014 16:08 (IST)
The company has received approval from the United States Food & Drug Administration (USFDA) for Calcitriol softgel capsules in the strengths of 0.25mcg and 0.5mcg, Strides Arcolab said in a statement.
December 16, 2014 13:18 (IST)
The company has launched Valganciclovir tablets, USP in the strength of 450 mg in the US market on December 15, 2014 and the product has been approved by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a filing to the BSE today.
December 15, 2014 21:38 (IST)
German drug makers including Stada, Torrent's Heumann and Dr. Reddy's Betapharm have appealed a regulator's decision to suspend approval of some drugs over concerns about clinical trials conducted by an Indian company.
December 15, 2014 14:55 (IST)
Drug firm Ranbaxy Laboratories has received regulatory nod to launch its indigenously developed anti-malarial drug Synriam in 7 African nations.
December 14, 2014 18:08 (IST)
The Mumbai-based firm, which is the fifth largest generic player in the US market, has so far stayed away from inorganic growth in India where it clocked revenues of Rs 2,479 crore in the previous fiscal.
December 13, 2014 11:00 (IST)
German drug maker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the Supreme Court ruled against it on Friday.
December 12, 2014 14:18 (IST)
India's drug price authority said in a notice that prices of 52 more drugs, including painkillers and antibiotics, are capped.
December 11, 2014 20:53 (IST)
Its US subsidiary, Lupin Pharmaceuticals Inc has launched the authorised generic for GD Searle LLC's (a subsidiary of Pfizer) Celebrex capsules of strength of 50 mg, 100 mg, 200 mg and 400 mg, the company said in a statement today.
December 10, 2014 14:21 (IST)
Drug major Cipla today said its Mauritius subsidiary Meditab Holdings has signed a deal to sell its entire 48.22 per cent stake in China-based Jiangsu Cdymax Pharmaceuticals for $18.5 million (over Rs 114 crore).
December 10, 2014 13:10 (IST)
The Federal Institute for Drugs and Medical Devices said yesterday it had ordered drug manufacturers, wholesale dealers, medical stores and other outlets not to sell or use these medicines any longer.
December 09, 2014 15:59 (IST)
Drug maker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its US price.
December 08, 2014 23:43 (IST)
Cadila Healthcare is voluntarily recalling 15,144 bottles of its anti-hypertension drug Amlodipine Besylate tablets in the US market, according to the US Food and Drug Administration (FDA).
December 08, 2014 18:14 (IST)
The Competition Commission of India (CCI) on Monday said it has approved generic drug maker Sun Pharmaceutical Industries Ltd's $3.2 billion bid to buy smaller rival Ranbaxy Laboratories Ltd, subject to the companies divesting seven products.
December 06, 2014 18:37 (IST)
The verdict, handed down Friday in federal court in Boston, is the first time a jury has decided such a case since the US Supreme Court ruled last year that so-called "pay-for-delay" settlements may run afoul of antitrust laws.
December 05, 2014 21:41 (IST)
Aurobindo Pharma acquired "manufacturing assets, personnel, commercial infrastructure including the nutraceuticals brands in USA of Natrol along with an agreement to take on certain liabilities, with a bid of $132.5 million", the company said in a statement.
December 04, 2014 15:38 (IST)
European authorities inspected all units at Ranbaxy's Dewas plant, in Madhya Pradesh, in June and did not approve the manufacturing practices at the unit that makes injectable cephalosporin antibiotics, Ranbaxy said in a stock market filing on Thursday.
December 03, 2014 23:43 (IST)
In fresh overseas troubles, drug maker Ranbaxy has been barred from exporting certain antibiotics produced at its Dewas plant to Germany for non-compliance to 'good manufacturing practice' norms.